JNJ

Johnson & Johnson (JNJ)

Last Price$159.61.1%
Market Cap$383.4B
LTM Net Debt to Free Cash Flow
0.7x
5Y avg
0.5x
Drug Manufacturers - General industry median
2.1x
Stock quality & Intrinsic value
6/10
0.2% undervalued

Johnson & Johnson Net Debt to Free Cash Flow

Annual
Quarterly
LTM
Industry median
Company stand-alone
JNJ
Healthcare
Crunching data... Almost there!
Jan'05Jan'06Dec'06Dec'07Dec'08Jan'10Jan'11Jan'12Dec'12Dec'13Dec'14Jan'16Jan'17Dec'17Dec'18Dec'19Jan'21Jan'22Jan'23Dec'23
Net Debt to Free Cash Flow
(1.1x)
(1.5x)
0.2x
0.0x
(0.1x)
(0.3x)
(0.8x)
(1.1x)
(0.4x)
(0.8x)
(1.0x)
(1.2x)
(1.0x)
0.9x
0.6x
0.4x
0.5x
0.1x
1.1x
0.4x
JNJ
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for JNJ and see if it's the right time to invest.
Dive in

Johnson & Johnson (JNJ) Net Debt to Free Cash Flow comparison analysis

Crunching data... Almost there!

JNJ key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is Johnson & Johnson's Net Debt to Free Cash Flow?

As of today, Microsoft Corp's last 12-month Net Debt to Free Cash Flow is 0.7x, based on the financial report for Dec 29, 2024 (Q4 2024). The average annual Net Debt to Free Cash Flow for Johnson & Johnson have been 0.5x over the past three years, and 0.5x over the past five years.

2) Is Johnson & Johnson's Net Debt to Free Cash Flow Good?

As of today, Johnson & Johnson's Net Debt to Free Cash Flow is 0.7x, which is lower than industry median of 2.1x. It indicates that Johnson & Johnson's Net Debt to Free Cash Flow is Good.

3) How does Johnson & Johnson's Net Debt to Free Cash Flow compare to its peers?

As of today, Johnson & Johnson's Net Debt to Free Cash Flow is 0.7x, which is lower than peer median of 2.1x. The list of peers includes LLY, AMGN, ABBV, AZN, BMY, NVS, GILD, PFE, SNY, MRK.